Search
Sihuan Pharma Receives Approval for Expanded Indication of Pyloxicillin Tablets
3 week ago /
Read about 0 minute
Author：小编
Sihuan Pharma, through its subsidiary Sinozhu Biopharmaceutical, has successfully secured acceptance from the National Medical Products Administration for a new drug application (NDA) of its innovative Class 1 drug, Pyloxicillin Tablets. This approval expands the indication of Pyloxicillin Tablets to include the treatment of advanced breast cancer, marking the third indication for the product. The latest indication aims to address the evolving treatment needs of patients diagnosed with HR+/HER2- advanced breast cancer.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
